Stockreport

Xeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023 [Yahoo! Finance]

Xeris Biopharma Holdings, Inc.  (XERS) 
Last xeris biopharma holdings, inc. earnings: 3/11 06:00 am Check Earnings Report
PDF Net Loss : Q4 net loss narrowed to $13.4M ($0.10 per share); full-year net loss stood at $62.3M ($0.45 per share). Cash Position : Ended 2023 with over $72M in cash, [Read more]